Article ID Journal Published Year Pages File Type
5692736 The Breast 2017 10 Pages PDF
Abstract
Despite the recommendation provided by current ESMO guidelines on mBC treatments, indicating the sequential use of single cytotoxic agents is a considerable alternative to standard multidrug chemotherapy regimens, marketing research data suggests this may not be reflected in EU prescribing behavior.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Treatment of metastatic breast cancer in EU: Analysis of market research data from 4Q2013 till 3Q2014
Authors
, ,